# FDA Inspection 1231026 - Penta International Corp - February 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/penta-international-corp/ed810a31-ac6c-4b95-abcb-7387dbf3aa8a
Source feed: FDA_Inspections

> FDA Inspection 1231026 for Penta International Corp on February 16, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231026
- Company Name: Penta International Corp
- Inspection Date: 2024-02-16
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1162293 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/penta-international-corp/36a3edd6-2d53-4905-a17f-de981b637da9)
- [FDA Inspection 700793 - 2010-12-08](https://www.keypedia.com/records/fda_inspections/penta-international-corp/34b9439a-38bd-443f-bec4-973ca4c0b2f6)

Company: https://www.keypedia.com/companies/penta-international-corp/5badff3c-a759-49f2-8a2a-95c9609225fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c